Sunday, March 29, 2014
1:00 p.m.–5:00 p.m.
The World Federation for the Treatment of Opioid Dependence (WFTOD) was founded during the European Opiate Addiction Treatment Association (EUROPAD) meeting of July 2007 in Ljubljana, Slovenia. All of the member nations, which included the member countries of EUROPAD and all of the member states within AATOD, agreed to a charter for the World Federation.
Chairman: Icro Maremmani, MD, Santa Chiara University Hospital, Pisa, Italy
Introductions: Michael Rizzi, AATOD International Committee Chair, Cranston, RI
1:00 p.m.–1:20 p.m.
Speaker: Alice Deschenau, MD, What’s Up Doc, Villejuif, France
The Misuse: A Part of Opioid Maintenance Treatment
A. Deschenau, D. Touzeau* (Villejuif, France, EU)
1:20 p.m.–1:40 p.m.
Speaker: Icro Maremmani, MD, Santa Chiara University Hospital, Pisa,Italy
Measuring Outcomes in Opioid Dependence Care: Expert Consensus on Need for Improved Outcome Measurement Tools
I. Maremmani (Pisa, Italy, EU), H. Alho* (Helsinki, Finland, EU), R. Littlewood* (London, UK)
1:40 p.m.–2:00 p.m.
Speaker: Lorenzo Somaini, MD, Addiction Treatment Center, Biella, Italy
Agonist Opioid Treatment and Sexual Dysfunctions
L. Somaini (Biella, Italy, EU)
2:00 p.m.–2:20 p.m.
Speaker: Samir Kasper, MD, Cantonal Institute for Addiction Zenica, Bosnia & Herzegovina
Replacement Therapy Method Resettlement in Prisons—Yes or No?
S. Kasper, J. Softic*, H. R. Awad* (Zenica, Bosnia & Herzegovina)
2:20 p.m.–2:40 p.m.
Speaker: Jody L. Green, PhD, Researched Abuse, Diversion, and Addiction-Related Surveillance (RADARS® System), Denver, CO
Emerging Trends in Alternative Routes Reported for Prescription Drug Misuse: An International Perspective
J. Green (Denver, CO, USA)
2:40 p.m.–3:00 p.m.
Speaker: Stephen R. Andrew, LCSW, Health Education and Training Institute, Portland, ME
Motivational Interviewing to Facilitate 12 Steps for Opiate Addiction
S. R. Andrew (Portland, ME, USA)
3:00 p.m.–3:20 p.m.
Speakers: André-Jean Remy, MD and Hugues Wenger, MD, CentreHospitalier de Perpignan, France
Treatment of Chronic Hepatitis C in Drug Users: Ethical,Successful, and Useful
A.J. Remy, H. Wenger, H. Bouchkira* (Perpignan, France, EU)
3:20 p.m.–3:40 p.m.
Speaker: Mirjana Delic, MD, Center for Treatment of Drug Addiction,
University Psychiatric Clinic Ljubljana, Slovenia Factors Associated with Outcome of Inpatient Opioid Addiction Treatment
M. Delic, L. Lusa*, P. Pregelj* (Ljubljana, Slovenia, EU)
3:40 p.m.–4:00 p.m.
Speaker: Einat Peles, PhD, Dr. Miriam & Sheldon G. Adelson Clinic for Drug Abuse, Treatment & Research, Tel Aviv,
Israel Risk Factors for Weight Gain during Methadone Maintenance Treatment
E. Peles, S. Schreiber*, A. Sason*, M. Adelson* (Tel Aviv, Israel)
4:00 p.m.–4:20 p.m.
Speaker: Thomas Clausen, MD, Norwegian Centre for Addiction Research, University of Oslo, Norway
Introducing a Naloxone Nasal-Spray Project as Part of a National Overdose Prevention Campaign in Norway: First Experiences and Results
T. Clausen (Oslo, Norway)
4:20 p.m.–4:40 p.m.
Speaker: Andrej Kastelic, MD, Center for Treatment of Drug Addiction, Ljubljana, Slovenia
Effectiveness of Medication-Assisted Treatment with Methadone, Buprenorphine, and Sustained Release Morphine
A. Kastelic (Ljubljana, Slovenia EU)
4:40 p.m.–5:00 p.m.
Questions & Answers
* Contributed to research but will not be presenting.
Sponsored by the American Association for the Treatment of Opioid Dependence, Inc. (AATOD), EUROPAD, and the World Federation for the Treatment of Opioid Dependence (WFTOD)
Please go to http://www.aatod.org/national-conference/2015-aatod-conference-atlanta/continuing-education-credit/ for more information on continuing education credits for each section of the website.